Texas is lifting its mask mandate, Gov. Greg Abbott said Tuesday, making it the largest state to no longer require one of the most effective ways to slow the spread of the coronavirus.The announcement in Texas, where the virus has killed more than 42,000 people, rattled doctors and big city leaders who said they are now bracing for another deadly resurgence. One hospital executive in Houston said he told his staff they would need more personnel and ventilators.Texas Governor Greg Abbott delivers an announcement in Montelongo’s Mexican Restaurant on March 2, 2021, in Lubbock. Abbott announced that he is rescinding executive orders that limit capacities for businesses and the state wide mask mandate.Federal health officials this week urgently warned states to not let their guard down, warning that the pandemic is far from over.Abbott, a Republican, has faced sustained criticism from his party in America’s biggest red state over the statewide mask mandate — which was imposed eight months ago — as well as business occupancy limits that Texas will also scuttle next week. The mask order was only ever lightly enforced, even during the worst outbreaks of the pandemic.”Removing statewide mandates does not end personal responsibility,” said Abbott, speaking from the crowded dining room of a restaurant in Lubbock, surrounded by several people not wearing masks.”It’s just that now state mandates are no longer needed,” he said.The repeals will take effect March 10.The full impact of Texas’ reversal was still coming into focus. Mark Cuban, owner of the NBA’s …
Zimbabwe Relaxes Lockdown as Coronavirus Cases Decrease
President Emmerson Mnangagwa has relaxed Zimbabwe’s coronavirus lockdown, saying new infections continue to decrease. Vendors welcome the move but say they need help buying protective equipment so they can safely operate. Meanwhile, the main opposition party says more needs to be done to help the country bounce back from the pandemic.In a nationally televised address late Monday, President Emmerson Mnangagwa said Zimbabwe was with immediate effect relaxing most lockdown regulations – which the country reimposed early January following a spike in cases.“It is noteworthy that the number of COVID-19 positive cases, fatalities and hospitalizations continue to steadily decrease. We must, however, remain alert and on guard to maintain this positive momentum attained so far. The government has rolled out the first phase of the national COVID-19 vaccination program which targets the front-line workers, security sector, and members of the media, the elderly and those with underlying conditions. More vaccines are coming and people will have the opportunity to be vaccinated,” said the president.The country started a vaccination drive last month after receiving 200,000 doses of the Sinopharm coronavirus vaccine donated by Chinese government.Samuel Wadzai welcomes, March 2, 2021, the government’s decision to allow informal traders to resume operating.(Columbus Mavhunga/VOA)Samuel Wadzai leads the activist group Vendors Initiative Social and Economic Transformation in Zimbabwe. He welcomed the government’s decision to allow informal traders to resume operating.“This is going to significantly help us to survive. The lockdown itself was causing a lot of suffering. The informal sector was heavily affected,” he said.But Wadzi wants the government …
US Drug Maker Merck to Help Produce Rival’s COVID Vaccine
U.S. pharmaceutical giant Merck has agreed to help manufacture rival Johnson & Johnson’s new coronavirus vaccine to help speed production of millions of new doses of the single shots to inoculate more Americans in the coming months, White House officials said Tuesday.Johnson & Johnson has encountered unexpected production problems, even as it won emergency use approval last weekend for the vaccine. The company has manufactured 3.9 million doses so far, but says it is on pace to produce 100 million doses by the end of June.President Joe Biden is set to spell out details of the agreement between the two pharmaceutical companies later Tuesday. But officials familiar with the deal say Merck will use two sites in the U.S., one to help make the vaccine and the other to provide “fill-finish” services, the final stage in the production process in which the vaccine is placed in vials and packaged for distribution.The Merck agreement with its drug-making rival could sharply increase the number of doses Johnson & Johnson could make on its own, the officials said. Merck failed in its efforts to develop its own coronavirus vaccine, but the company has made vaccines for a century. It is the sole U.S. supplier of the combination childhood vaccine that protects against measles, mumps and rubella. It developed Gardasil, which protects against the human papillomavirus, while the Food and Drug Administration approved its Ebola vaccine in 2019.With the approval of the single-shot Johnson & Johnson vaccine, the U.S. now has three medical treatments …
COVAX Program to Roll Out Tens of Millions of Vaccine Doses Globally
The global COVAX vaccine distribution plan aims to deliver tens of millions of vaccine doses to low-income countries — many of them in Africa – in the coming months, top global health officials say, describing this as a turning point in the quest to quash the coronavirus pandemic.The world’s largest, fastest, and most ambitious vaccine drive delivered 11 million vaccine doses Tuesday to Angola, Cambodia, the Democratic Republic of the Congo and Nigeria. Between now and the end of May, said WHO chief Tedros Adhanom Ghebreyesus, the COVAX facility will deliver 270 million doses to 142 participating countries and economies.The global initiative was set up last April to ensure that poorer nations aren’t left out of the worldwide scramble for vaccine access. The program, which is projected to cost about $11 billion, is funded by donor nations, foundations and corporations. It is part of the Access to COVID-19 Tools Accelerator, a global collaboration that works on the development, production, and equitable access to tests, treatments, and vaccines.Last week, the West African nation of Ghana became the first to benefit from COVAX, receiving 600,000 doses of the AstraZeneca vaccine. Among the first recipients were President Nana Akufo-Addo and the first lady, who received their shots on national television Monday in what he said was an effort to boost public confidence in the vaccine. Akufo-Addo plans to vaccinate the rest of his country by the end of the year, he said. “The world has seen already the great value of the COVAX …
France Reverses Course on Using AstraZeneca COVID-19 Vaccine on Citizens Over 65
France will now vaccinate people aged 65 years and older with the COVID-19 vaccine jointly developed by Oxford University and British-Swedish drugmaker AstraZeneca. The decision was announced Tuesday by Health Minister Olivier Veran during a televised interview. Veran said anyone older than the age of 50 with pre-existing conditions can receive the Oxford-AstraZeneca vaccine, “including those between 65 and 74.” France was among many European nations that refused to approve the Oxford-AstraZeneca for its elderly citizens. The developers did not enroll many people in those age groups for their large-scale clinical trials, leading to a lack of data about its potential efficacy. French President Emmanuel Macron even went so far as describing the vaccine as “quasi-ineffective.” FILE – A medical worker holds a vial of the Oxford-AstraZeneca vaccine against the coronavirus disease (COVID-19) in a mass vaccination center at the Cecchignola military compound, in Rome, Italy, Feb. 23, 2021.But health officials say further data from clinical trials has proved its efficacy among older people. The reversal is sure to jumpstart France’s slow vaccination campaign, which has been hampered by a shortage of vaccines from Pfizer-BioNTech and Moderna. France’s change of heart coincides with a real-world study conducted in Britain that found the COVID-19 vaccines developed by Pfizer-BioNTech and Oxford University-AstraZeneca are highly effective in protecting elderly people from the disease after receiving just one shot. Researchers at Public Health England say the respective two-dose vaccines are more than 80% effective at preventing people in their 80s from being hospitalized around three to …
One in Four People Will Have Hearing Problems by 2050, WHO Says
One in four of the world’s population will suffer from hearing problems by 2050, the World Health Organization warned Tuesday, calling for extra investment in prevention and treatment. The first-ever global report on hearing said that the causes of many of the problems — such as infections, diseases, birth defects, noise exposure and lifestyle choices — could be prevented. The report proposed a package of measures, which it calculated would cost $1.33 per person per year. Against that, it set the figure of nearly $1 trillion lost every year because the issue was not being properly addressed. “Failure to act will be costly in terms of the health and well-being of those affected, and the financial losses arising from their exclusion from communication, education and employment,” said the report. One in five people worldwide have hearing problems currently, it said. But the report warned: “The number of people with hearing loss may increase more than 1.5-fold during the next three decades” to 2.5 billion people — up from 1.6 billion in 2019. Of the 2.5 billion, 700 million would in 2050 have a serious enough condition to require some kind of treatment, it added — up from 430 million in 2019. Much of the expected rise is the result of demographic and population trends, it added. Poor access to treatment A major contributor to hearing problems is a lack of access to care, which is particularly striking in low-income countries where there are far fewer professionals available to treat them. Since nearly 80% of people with hearing loss live in such countries, most are not getting …
Third Vaccine Arrives as Another COVID Surge Looms
A third COVID-19 vaccine is heading to clinics and pharmacies across the United States. But U.S. health officials are warning that another surge in cases could be on the horizon.Regulators authorized the vaccine from pharmaceutical company Johnson & Johnson over the weekend. Nearly 4 million doses are expected to be available at vaccination sites beginning as soon as Tuesday.But after a sharp fall over the past several weeks, the number of COVID-19 cases and deaths has increased again. Experts are concerned that newer, more infectious variants of the coronavirus that causes COVID-19 may be taking over.The reversal comes as most states are easing restrictions that contain the disease.”Now is not the time to relax the critical safeguards that we know can stop the spread of COVID-19,” Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, said at a press briefing of the White House COVID-19 Response Team.Though the numbers have declined, the National Guard personnel check in people as they wait to receive a COVID-19 vaccination, Feb. 26, 2021, in Shelbyville, Tennessee.”Please hear me clearly,” Walensky said. “At this level of cases with variants spreading, we stand to completely lose the hard-earned ground we have gained. These variants are a very real threat to our people and our progress.”Effective against severe diseaseThe Johnson & Johnson vaccine was about 85% effective in preventing severe illness in a clinical trial spanning eight countries on three continents.That includes South Africa, where a more transmissible coronavirus variant dominates cases.”Even though the …
Deadly Drug Overdoses Epidemic Rages On
More than 86,000 people died from drug overdoses last year in the U.S. – a massive increase of just over 24 percent. It is an epidemic that as VOA’s Veronica Balderas Iglesias reports, has been shoved in the shadows by the pandemic – but is no less serious a public health issue.Camera: Veronica Balderas Iglesias Produced by: Veronica Balderas Iglesias …
Iceberg Bigger Than NYC Breaks off From Antarctica
Scientists with the British Antarctica Survey (BAS) say a huge iceberg — larger than New York City — has broken off from the northwestern Brunt Ice Shelf in Antarctica, almost 10 years after scientists discovered the first cracks. In a statement on its website, the BAS says the iceberg broke away Friday and that it covers about 1,270 square kilometers. The BAS says the mass is about 150 meters thick. The agency said Halley Research Station, also situated on Brunt Ice Shelf, is not expected to be impacted as it is located on an area of the ice shelf still connected to the continent. The BAS took the precaution of moving the station in 2016 to avoid the paths of cracks in the ice its staff had been observing. In the statement, the BAS director, Professor Dame Jane Francis, said agency scientists were expecting the break, known as calving, to happen, after daily monitoring of the area with GPS instruments and satellite imagery. Francis said the iceberg is expected to either move away or run aground not far from the Brunt Ice Self. …
International Study Shows COVID-19 Vaccine Likely Uptake on the Rise
An international study shows an upward trend in support for receiving COVID-19 vaccines in several countries compared to the end of 2020, with the biggest increase in Britain and Sweden. Multinational communication firm Kekst CNC Monday published the results of the survey conducted in six countries – Britain, France, Germany, Japan, Sweden, and United States. The poll indicated 89% of Britons were in favor of getting vaccinated now, compared to 65% last September.The AstraZeneca vaccine is prepared in the COVID-19 vaccination center at the Odeon Luxe Cinema in Maidstone, Britain, Feb. 10, 2021.In Sweden, 76% of those interviewed were in favor of inoculation, compared to 51% in September 2020. The study shows that 68% of men worldwide support vaccination, the ratio is lower among women at 55%. Older and middle-aged people have become more likely to get a vaccine since September, the survey found. The study also shows that 75% of Britons are pleased with the pace of the vaccination campaign in the country, but the ratio drops in the other countries surveyed, to 32% in U.S., 22% in France and 20% in Sweden. Kekst CNC conducted the survey in mid-February over ten days, with samples of 1,000 adults in each country and margin of error of 3.3 percent for all participating counties. Sunday, a U.S. Centers for Disease Control and Prevention advisory panel endorsed the Johnson & Johnson vaccine, voting overwhelmingly to recommend the shot for adults older than 18. CDC recommendations are not binding but are widely respected by medical institutions and professionals. CDC Director Rochelle Walensky later approved the panel’s recommendations.FILE – Vials of Johnson & Johnson’s Janssen coronavirus disease (COVID-19) vaccine candidate are seen in an undated photograph.Sunday’s CDC endorsement came one day after the U.S. Food and Drug Administration formally authorized the use of the one-dose vaccine. Nearly 4 million doses of the Johnson & Johnson vaccine will be distributed and available as early as Tuesday morning, according to a senior administration official. This vaccine, the third to be approved for use in the United States, will be distributed to states, …
Philippines Finally Receives First Batch of COVID-19 Vaccine
The Philippines launched its national coronavirus vaccination campaign Monday amid widespread public skepticism and a struggle to procure vaccines. Dr. Gerardo Legaspi, the director of the state-run Philippine General Hospital in Manila, received the first dose of the CoronaVac vaccine developed by China-based Sinovac Biotech Limited. The doctor’s inoculation came just hours after President Rodrigo Duterte greeted the arrival of 600,000 doses of Sinovac donated by Beijing. The Philippines is the last Southeast Asian nation to receive a COVID-19 vaccine supply. The Duterte administration is aiming to vaccinate 70 million of its citizens, but some public opinion polls have revealed a resistance among a majority of people due to uncertainty over the safety and efficacy of the CoronaVac vaccine.Used vials of China’s Sinovac vaccine are shown during the first batch of vaccination at the Lung Center of the Philippines in Quezon city, Philippines on March 1, 2021.But Carlito Galvez, who is leading the Philippines’ vaccine procurement efforts, urged his compatriots to get the first vaccine that becomes available. “Let’s not wait for the best vaccine. There’s no such thing,” Galvez said in a speech at the Philippine General Hospital. “The best vaccine is the one that’s safe and effective, and arrives early.” But just receiving vaccines has been an issue. An expected shipment of 525,600 doses of the AstraZeneca-Oxford University vaccine that was due Monday has been postponed due to supply problems. The COVID-19 pandemic has devastated the Pacific archipelago, sickening more than 576,000 people, including 12,318 deaths, the second-highest in the region. President Duterte has vowed to ease some of the restrictions imposed in an effort to boost …